BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25133039)

  • 1. Diagnosis and treatment of gastroesophageal reflux disease.
    Badillo R; Francis D
    World J Gastrointest Pharmacol Ther; 2014 Aug; 5(3):105-12. PubMed ID: 25133039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of gastroesophageal reflux disease : diagnosis and treatment.
    Chuang TW; Chen SC; Chen KT
    Acta Gastroenterol Belg; 2017; 80(3):396-404. PubMed ID: 29560670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
    Armstrong D; Marshall JK; Chiba N; Enns R; Fallone CA; Fass R; Hollingworth R; Hunt RH; Kahrilas PJ; Mayrand S; Moayyedi P; Paterson WG; Sadowski D; van Zanten SJ;
    Can J Gastroenterol; 2005 Jan; 19(1):15-35. PubMed ID: 15685294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
    Pohle T; Domschke W
    Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux disease: A review of surgical decision making.
    Moore M; Afaneh C; Benhuri D; Antonacci C; Abelson J; Zarnegar R
    World J Gastrointest Surg; 2016 Jan; 8(1):77-83. PubMed ID: 26843915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.
    Soll AH; Fass R
    Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
    Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory Gastroesophageal Reflux Disease: Diagnosis and Management.
    Davis TA; Gyawali CP
    J Neurogastroenterol Motil; 2024 Jan; 30(1):17-28. PubMed ID: 38173155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease. Control of symptoms, prevention of complications.
    Kaynard A; Flora K
    Postgrad Med; 2001 Sep; 110(3):42-4, 47-8, 51-3. PubMed ID: 11570205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
    Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
    Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal Reflux Disease: A Review.
    Maret-Ouda J; Markar SR; Lagergren J
    JAMA; 2020 Dec; 324(24):2536-2547. PubMed ID: 33351048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the diagnosis and management of gastroesophageal reflux disease.
    Katzka DA; Kahrilas PJ
    BMJ; 2020 Nov; 371():m3786. PubMed ID: 33229333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
    Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
    Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.